CCPN SPAF Tool
CCPN SPAF Tool is a clinical reference app for Canadian healthcare professionals that calculates stroke and bleeding risk for atrial fibrillation patients.
The App DNA
What makes this app unique?
The tool removes the cognitive friction of manual guideline lookup by consolidating complex risk scores and dosing information into a single mobile interface.
For Canadian healthcare professionals managing patients with nonvalvular atrial fibrillation.
What does it look like?
Key features
Calculates stroke risk using CHADS and CHADSVASc criteria for patients with nonvalvular atrial fibrillation.
Evaluates patient bleeding risk using HAS-BLED criteria.
Provides recommendations based on Canadian Cardiovascular Society AFIB Guidelines and includes creatinine clearance calculations.
How much does it cost?
The tool is supported by unrestricted grants from pharmaceutical alliances, removing cost barriers for professional users.
Velocity
Dormant developmentopaqueShow more...
The app is currently in a zombie state, having shipped only one minor update in the last 266 days. There is no evidence of active development, new feature releases, or ongoing maintenance. The last release was limited to a copyright year update, indicating a lack of functional progress or engagement efforts.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for CCPN SPAF Tool
How's the Medical market?
CCPN SPAF Tool occupies a specialized niche in the Canadian medical category, acting as a digital companion to the CCPN SPAF pocket card.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for CCPN SPAF Tool
Where is it heading?
The clinical reference market is consolidating around tools that offer real-time guideline integration. CCPN SPAF Tool remains stable due to its specific Canadian focus, but it risks losing relevance if the underlying CCS guidelines shift without a corresponding update cadence.
- The eight-month update dormancy indicates a maintenance-only posture, which is sufficient for static clinical guidelines but limits future growth potential.
The SWOT
- CCS AFIB guideline integration provides high-trust clinical utility
- Grant-funded model removes cost barriers for professional adoption
- Interactive patient-management alerts could increase daily utility
Next best moves
Audit guideline currency because the eight-month update gap risks clinical obsolescence → maintain professional trust
The counter-intuitive read
The tool's lack of updates is a feature, not a bug…
Read the full takeBottom line
CCPN SPAF Tool provides a stable, grant-funded clinical reference that serves a specific Canadian professional segment. Maintaining the accuracy of the integrated CCS guidelines is the primary lever for retaining user trust in a maintenance-mode product.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated